Cleerly Launches Cleerly ISCHEMIA Solution for Heart Disease Analysis
FDA cleared, evidence-based AI and machine learning-based algorithm detects heart disease-associated ischemia
Cleerly, Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at AHA 2023
Cleerly, Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023 Data from...
Cleerly joins AHA Center for Health Technology & Innovation Innovators’ Network
Cleerly joins American Heart Association Center for Health Technology & Innovation Innovators’ Network American Heart Association consortium advances...
Cleerly Takes Center Stage as Best Use of AI in Health Tech Winner at the Fifth Annual Digital Health Hub Foundation Awards
Award recognizes Cleerly’s AI-based digital care platform for heart disease analysis at HLTH 2023 Denver – October 11, 2023 -- Cleerly, the company...
